roberts
pharmaceutical
corp
said
wednesday
wholly
owned
roberts
laboratories
unit
received
exclusive
license
pfizer
develop
market
sampatrilat
new
compound
treat
essential
hypertension
congestive
heart
failure.the
agreement
provides
transfer
data
assignment
patent
rights
roberts
pfizer.financial
details
disclosed
